Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Why NETGEAR Shares Are Trading Lower By 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Published 27/04/2023, 17:48
Updated 27/04/2023, 19:10
© Reuters.  Why NETGEAR Shares Are Trading Lower By 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

© Reuters. Why NETGEAR Shares Are Trading Lower By 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Benzinga - Gainers

  • Evelo Biosciences, Inc. (NASDAQ: EVLO) jumped 147.9% to $0.2479. Evelo Biosciences shares dropped 33% on Wednesday after the company announced top-line data from the fourth cohort of its EDP1815 Phase 2 trial, in which the primary endpoint was not met.
  • ContraFect Corporation (NASDAQ: CFRX) gained 87% to $2.4693. ContraFect said first patient was dosed in the Phase 1b/2 study of exebacase in patients with chronic prosthetic joint infections of the knee.
  • Hillstream BioPharma, Inc. (NASDAQ: HILS) jumped 56% to $1.10.
  • TOP Financial Group Limited (NASDAQ: TOP) rose 53.7% to $10.33.
  • U Power Limited (NASDAQ: UCAR) climbed 33.5% to $5.45 after declining around 27% on Wednesday.
  • Atomera Incorporated (NASDAQ: ATOM) shares gained 23.6% to $6.45 after the company posted results for its first quarter. The company announced the execution of a commercial license agreement with STMicroelectronics (ST) that enables the latter to install Atomera's Mears Silicon Technology into its facilities.
  • OMNIQ Corp. (NASDAQ: OMQS) climbed 20.8% to $5.47.
  • Vapotherm, Inc. (NYSE: VAPO) rose 19.4% to $0.5001.
  • Helen of Troy Limited (NASDAQ: HELE) shares gained 19.1% to $97.39 after the company announced better-than-expected Q4 results.
  • Nuburu, Inc. (NYSE: BURU) gained 19% to $1.13.
  • Bel Fuse Inc. (NASDAQ: BELFB) rose 18.3% to $36.25 following better-than-expected quarterly results.
  • Immuron Limited (NASDAQ: IMRN) gained 16.4% to $2.23.
  • CXApp Inc. (NASDAQ: CXAI) climbed 16% to $10.74.
  • Mainz Biomed N.V. (NASDAQ: MYNZ) gained 15.6% to $3.92.
  • Accuray Incorporated (NASDAQ: ARAY) jumped 15% to $3.1050 after the company reported better-than-expected Q3 EPS and sales results.
  • LianBio (NASDAQ: LIAN) rose 14.7% to $2.26. LianBio announced topline results from the Phase 3 EXPLORER-CN trial investigating mavacamten for Chinese patients with symptomatic obstructive hypertrophic cardiomyopathy (oHCM).
  • Meta Platforms, Inc. (NASDAQ: META) climbed 14.3% to $239.64 as the company reported better-than-expected Q1 results and also announced an increase in active users.
  • Immix Biopharma, Inc. (NASDAQ: IMMX) gained 14.1% to $2.13 after Nexcella, an Immix Biopharma subsidiary, disclosed positive 58-patient NXC-201 clinical data.
  • GRI Bio, Inc. (NASDAQ: GRI) gained 14.1% to $6.79.
  • Goosehead Insurance, Inc (NASDAQ: GSHD) jumped 13.8% to $61.15 following upbeat quarterly results.
  • Overstock.com, Inc. (NASDAQ: OSTK) rose 13.7% to $20.54 following strong quarterly results.
  • Ardagh Metal Packaging S.A. (NYSE: AMBP) gained 13.5% to $3.93 following Q1 results.
  • Materialise NV (NASDAQ: MTLS) gained 13% to $8.80 as the company posted upbeat Q1 results and named Koen Berges as CFO.
  • Cimpress plc (NASDAQ: CMPR) jumped 12.4% to $48.72 following strong quarterly sales.
  • Hasbro, Inc. (NASDAQ: HAS) gained 10.8% to $57.00 after the company reported better-than-expected Q1 sales results and reiterated FY23 adjusted EPS guidance above the estimate.
  • Mangoceuticals, Inc (NASDAQ: MGRX) surged 10.7% to $1.3418 after dropping around 33% on Wednesday. Mangoceuticals recently commenced online sales campaign with DojoLabs Group.
  • Getaround, Inc. (NYSE: GETR) climbed 9.9% to $0.4999. Getaround received continued listing standard notice from NYSE related to delayed filing of Form 10-K.
  • Kaiser Aluminum Corporation (NASDAQ: KALU) gained 9.7% to $63.82 following Q1 results.
  • OpGen, Inc. (NASDAQ: OPGN) gained 6% to $0.88 after the company said its German subsidiary Curetis GmbH has met the remaining key milestones under the initial research and development collaboration agreement with FIND.
Losers
  • Baudax Bio, Inc. (NASDAQ: BXRX) fell 52.5% to $0.8406 after the company reported the pricing of $4 million public offering.
  • Impinj, Inc. (NASDAQ: PI) dropped 35.2% to $87.71 after the company reported mixed Q1 results and issued weak guidance.
  • 4D Molecular Therapeutics, Inc. (NASDAQ: FDMT) shares fell 31.1% to $14.18. 4DMT presented interim data from intravitreal 4D-150 Phase 1/2 PRISM clinical trial in patients with wet AMD at ARVO 2023.
  • Aspen Technology, Inc. (NASDAQ: AZPN) fell 25% to $173.76 after the company posted downbeat Q3 results and issued weak FY23 forecast.
  • Mobileye Global Inc. (NASDAQ: MBLY) dropped 22% to $33.58 after the company lowered FY23 revenue guidance below estimates.
  • Crown ElectroKinetics Corp. (NASDAQ: CRKN) fell 20.6% to $0.1206. Crown Electrokinetics recently issued a letter to shareholders.
  • Satixfy Communications Ltd. (NYSE: SATX) dropped 19.8% to $0.8101.
  • PROCEPT BioRobotics Corporation (NASDAQ: PRCT) fell 19.2% to $28.89 following wider-than-expected Q1 loss.
  • Crocs, Inc. (NASDAQ: CROX) fell 18.5% to $120.35 after the company reported Q1 earnings results and after the company issued Q2 guidance.
  • ETAO International Co., Ltd. (NASDAQ: ETAO) shares dropped 18.3% to $0.96 after gaining around 57% on Wednesday.
  • NETGEAR, Inc. (NASDAQ: NTGR) dipped 18.1% to $13.77 following weak quarterly results.
  • Ideanomics, Inc. (NASDAQ: IDEX) fell 17.2% to $0.0227 after dropping around 22% on Wednesday.
  • Kuke Music Holding Limited (NYSE: KUKE) dropped 16.9% to $0.60.
  • Wolfspeed, Inc. (NYSE: WOLF) fell 16.2% to $48.11 after the company issued weak Q4 guidance.
  • Avinger, Inc. (NASDAQ: AVGR) fell 15.5% to $0.54.
  • MaxLinear, Inc. (NYSE: MXL) dipped 15.5% to $24.78 after the company issued weak Q2 guidance.
  • IN8bio, Inc. (NASDAQ: INAB) fell 13.3% to $1.6902. IN8bio announced oral presentation of new INB-200 Phase 1 data in glioblastoma to be presented at 2023 ASCO Annual Meeting.
  • H&E Equipment Services, Inc. (NASDAQ: HEES) declined 12% to $36.36 following Q1 results.
  • Align Technology, Inc. (NASDAQ: ALGN) fell 11.7% to $312.85 after the company reported Q1 financial results and issued guidance.
  • Opera Limited (NASDAQ: OPRA) dropped 11.6% to $10.04 following Q1 results.
  • Sonic Automotive, Inc. (NYSE: SAH) gained 11.3% to $46.28 following weak quarterly results.
  • American Rebel Holdings, Inc. (NASDAQ: AREB) shares fell 11% to $0.1371 after gaining around 14% on Wednesday.
  • National Energy Services Reunited Corp. (NASDAQ: NESR) dipped 11% to $2.94 after the company announced it was not able to file its Annual Report on Form 20-F for its fiscal year ended December 31, 2021 with the SEC.
  • Clearmind Medicine Inc. (NASDAQ: CMND) fell 10.5% to $0.62. CONMED said it sees FY23 EPS of $3.30 to $3.50 and revenue of $1.205 billion to $1.250 billion.
  • Morningstar, Inc. (NASDAQ: MORN) dropped 9.3% to $172.95 following Q1 results.
  • AbbVie Inc. (NYSE: ABBV) dropped 8.5% to $147.95 after the company reported Q1 financial results and issued FY23 guidance.
  • Mobiquity Technologies, Inc. (NASDAQ: MOBQ) fell 8.4% to $0.1718 after jumping 22% on Wednesday. Mobility Technologies recently announced its AI-powered ad targeting technology.
  • STMicroelectronics N.V. (NYSE: STM) shares dropped 8.4% to $42.37 after reporting Q1 results.
Now Read This: Top 5 Health Care Stocks That Could Sink Your Portfolio This Quarter

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.